Your Source for Venture Capital and Private Equity Financings

SamaCare Closes $12M Series A

2022-06-02
SAN FRANCISCO, CA, SamaCare, a prior authorization platform for physician-administered medications, announced the close of a $12 million Series A funding.
SamaCare, a prior authorization platform for physician-administered medications, announced the close of a $12 million Series A funding round led by Clearlake Capital-backed Vive Collective, with participation from existing investors including NextView Ventures, South Park Commons, and Susa Capital.

SamaCare helps pharmaceutical manufacturers, providers, payors, and other stakeholders quickly and cost-effectively deliver life-changing therapies to patients. The company provides a cloud-based workflow automation platform for medical practices to streamline specialty drug prior authorization, enrollment, and benefit verification. In addition, SamaCare delivers premium services and data analytics for pharmaceutical brands to improve access to therapy.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors


Featured Reading